Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Clinical trial NCT03564405 · COMPLETED

Trial details

NCT number: NCT03564405
Sponsor: Jeil Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2016-12-05
Primary completion: 2017-03-07
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.